Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
:TOI
RESEARCH TOOLSreports
TOI Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.13 - $1.78
Previous CloseN/A
Volume198.36K
Average Volume (3M)589.24K
Market Cap
$91.43M
Enterprise Value$96.96M
Total Cash (Recent Filing)-$2.45M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.92
Next Earnings
May 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding75,559,074
10 Day Avg. Volume552,761
30 Day Avg. Volume589,236
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.20
Price to Cash Flow (P/CF)23.00
P/FCF Ratio44.90
Enterprise Value/Market Cap1.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.63
Enterprise Value/Ebitda-1.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Oncology Institute, Inc. News
PremiumCompany Announcements
Oncology Institute, Inc. Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
The Oncology Institute Reports Strong Q4 Revenue GrowthPremiumCompany Announcements
Oncology Institute, Inc. Prepares for PIPE Financing
PremiumCompany Announcements
Oncology Institute Amends Facility Agreement with Deerfield---
Ownership Overview
4.61% Insiders
2.71% Mutual Funds
12.76% Other Institutional Investors
77.54% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TOI FAQ
What was Oncology Institute, Inc.’s price range in the past 12 months?
Oncology Institute, Inc. lowest stock price was $0.13 and its highest was $1.78 in the past 12 months.
What is Oncology Institute, Inc.’s market cap?
Oncology Institute, Inc.’s market cap is $91.43M.
When is Oncology Institute, Inc.’s upcoming earnings report date?
Oncology Institute, Inc.’s upcoming earnings report date is May 07, 2025 which is in 41 days.
How were Oncology Institute, Inc.’s earnings last quarter?
Oncology Institute, Inc. released its earnings results on Mar 24, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.14.
Is Oncology Institute, Inc. overvalued?
According to Wall Street analysts Oncology Institute, Inc.’s price is currently Overvalued.
Does Oncology Institute, Inc. pay dividends?
Oncology Institute, Inc. does not currently pay dividends.
What is Oncology Institute, Inc.’s EPS estimate?
Oncology Institute, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Oncology Institute, Inc. have?
Oncology Institute, Inc. has 75,559,074 shares outstanding.
What happened to Oncology Institute, Inc.’s price movement after its last earnings report?
Oncology Institute, Inc. reported an EPS of -$0.14 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 24%.
Which hedge fund is a major shareholder of Oncology Institute, Inc.?
Currently, no hedge funds are holding shares in TOI
---
Oncology Institute, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $50.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.40%
12-Months-Change
Fundamentals
Return on Equity
-174.88%
Trailing 12-Months
Asset Growth
-17.10%
Trailing 12-Months
Company Description
Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
---
TOI Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and strategic expansions into new markets, with improved financial flexibility from debt reduction and capital raises. However, the company continues to face profitability challenges, with a net loss and negative adjusted EBITDA reported for 2024. Efforts to improve cash flow and cost efficiency are promising, but overall profitability remains a challenge.Read More>---
TOI Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Plus Therapeutics
―
Enzo Biochem
―
Sorrento Therapeutics
―
Actinium Pharmaceuticals
―
Citius Pharmaceuticals
―
Best Analysts Covering TOI
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
+59.70%
reiterated a buy rating 10 months ago
Copying Jack Slevin's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +59.70% per trade.
---